DGLCX
Price
$18.24
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Net Assets
802.09M
FNPFX
Price
$66.06
Change
+$0.06 (+0.09%)
Updated
May 22 closing price
Net Assets
147.5B
Interact to see
Advertisement

DGLCX vs FNPFX

Header iconDGLCX vs FNPFX Comparison
Open Charts DGLCX vs FNPFXBanner chart's image
BNY Mellon Global Stock - C
Price$18.24
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets802.09M
American Funds New Perspective F3
Price$66.06
Change+$0.06 (+0.09%)
VolumeN/A
Net Assets147.5B
DGLCX vs FNPFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DGLCX vs. FNPFX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGLCX is a Buy and FNPFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FNPFX has more cash in the bank: 148B vs. DGLCX (802M). FNPFX pays higher dividends than DGLCX: FNPFX (0.88) vs DGLCX (0.00). DGLCX was incepted earlier than FNPFX: DGLCX (18 years) vs FNPFX (8 years). DGLCX (2.01) is less costly to investors than FNPFX (0.41). FNPFX is a more actively managed with annual turnover of: 24.00 vs. DGLCX (10.58). DGLCX has a lower initial minimum investment than FNPFX: DGLCX (1000) vs FNPFX (1000000). FNPFX annual gain was more profitable for investors over the last year : 7.31 vs. DGLCX (-6.60). FNPFX return over 5 years is better than : 52.04 vs. DGLCX (-8.48).
DGLCXFNPFXDGLCX / FNPFX
Total Expense Ratio2.010.41490%
Annual Report Gross Expense Ratio2.010.41490%
Fund Existence18 years8 years-
Gain YTD1.2586.28020%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets802M148B1%
Annual Yield % from dividends0.000.88-
Returns for 1 year-6.607.31-90%
Returns for 3 years-10.0833.32-30%
Returns for 5 years-8.4852.04-16%
Returns for 10 years-2.69N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LICCX16.88N/A
N/A
Lord Abbett International Equity C
ETNHX31.33N/A
N/A
Eventide Healthcare & Life Sciences N
FLKSX15.17N/A
N/A
Fidelity Low-Priced Stock K6
LCISX26.12N/A
N/A
ClearBridge Sustainability Leaders I
CFIHX73.81-0.62
-0.83%
American Funds Capital Income Bldr F3